Immunomodulation of experimental APS: Lessons from murine models

Research output: Contribution to journalArticlepeer-review

Abstract

During the last few years several murine models for APS have been described. These include spontaneous occurring disease, or APS induced by immunization with pathogenic autoantibodies. Employing those models, several treatment modalities, in different stages of the disease, were studied. Treatments which showed promising potential for application in patients with APS include immunomodulation with specific anti-idiotypic or anti-CD4 antibodies, treatment with IL-3, high-dose intravenous immunoglobulins, ciprofloxacin or bromocriptine, as well as antithrombotic and anticoagulant treatments using aspirin and/or low-molecular-weight heparin. Bone-marrow transplantation was also found to improve clinical and serological manfestations of the disease. These studies might promote the handling of controlled clinical trials assessing their efficacy in APS patients.

Original languageEnglish
Pages (from-to)458-462
Number of pages5
JournalLupus
Volume5
Issue number5
DOIs
StatePublished - 1996

Keywords

  • Anticardiolipin antibodies
  • Antiphospholipid syndrome
  • Autoimmunity
  • Idiotypes
  • Interleukin-3
  • Systemic lupus erythematosus

Fingerprint

Dive into the research topics of 'Immunomodulation of experimental APS: Lessons from murine models'. Together they form a unique fingerprint.

Cite this